Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Sep 6:22:3154-62.
doi: 10.12659/msm.896563.

Assessing Clinical Significance of Serum CA15-3 and Carcinoembryonic Antigen (CEA) Levels in Breast Cancer Patients: A Meta-Analysis

Yijie Fu  1 , Hui Li  1
Affiliations
Meta-Analysis

Assessing Clinical Significance of Serum CA15-3 and Carcinoembryonic Antigen (CEA) Levels in Breast Cancer Patients: A Meta-Analysis

Yijie Fu et al. Med Sci Monit. .

Abstract

BACKGROUND Breast cancer is the most common malignant cancer in women worldwide. The tumor markers Cancer Antigen 15-3 (CA15-3) and Carcinoembryonic Antigen (CEA) are frequently used for screening and monitoring breast cancer. MATERIAL AND METHODS We conducted a meta-analysis of 13 published case-control studies to assess the associations between serum levels of CA15-3 and CEA with breast cancer susceptibility, including 1179 cases and 493 controls. The analyses were performed on malignant tumor and benign tumor, as well as in different subgroups with respect to the patient ethnicities and clinical tumor stages. RESULTS This systematic review and meta-analysis of association studies shows that serum levels of CA15-3 and CEA are potential biomarkers for breast cancer monitoring. When stratified by clinical stage, we noticed that although malignant tumors in all stages show elevated levels of CA15-3, it is greatly associated with the tumor stage, as it increases as breast tumor stage worsens. CONCLUSIONS This study clarifies the inconsistent conclusions from multiple studies, and provides a precise estimation for clinical utility of 2 important biomarkers, CA15-3 and CEA, in breast cancer monitoring. Thus, our study will shed lights on the prognosis of breast cancer patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of article collection.
Figure 2
Figure 2
Forest plots of (A) CA15-3 for malignant tumor, (B) CEA for malignant tumor, and (C) CA15-3 for benign tumor.
Figure 3
Figure 3
Funnel plots of (A) CA15-3 for malignant tumor and (B) CEA for malignant tumor.
Figure 4
Figure 4
Forest plots of CA15-3 for (A) Caucasian population and (B) Asian population.
Figure 5
Figure 5
Forest plots of CEA for (A) Caucasian population and (B) Asian population.
Figure 6
Figure 6
Forest plots of CA15-3 for (A) stage I, (B) stage II and (C) stage III tumor.
Figure 7
Figure 7
Funnel plots of CA15-3 for (A) stage I, (B) stage II and (C) stage III tumor.
See this image and copyright information in PMC

References

    1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. Cancer J Clin. 2000;50(1):7–33. - PubMed
    1. Stewart BW, Wild C International Agency for Research on Cancer, World Health Organization. World cancer report. 2014.
    1. Taplin S, Abraham L, Barlow WE, et al. Mammography facility characteristics associated with interpretive accuracy of screening mammography. J Natl Cancer Inst. 2008;100(12):876–87. - PMC - PubMed
    1. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738–47. - PMC - PubMed
    1. O’Hanlon DM, Kerin MJ, Kent P, et al. An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma. Br J Cancer. 1995;71(6):1288–91. - PMC - PubMed